28 November 2022

Amicus Therapeutics is sponsoring the “Young Investigator Excellence in Research Programme for research focused on late-onset Pompe disease (LOPD) or infantile-onset Pompe disease (IOPD).  The details of this offer are available on an online leaflet available through the link: https://amicuseducation.co.uk/wp-content/uploads/2022/11/your-research-in-pompe-disease.pdf

It is aimed at young researchers that are active in the field of Pompe disease (research, clinical practice or other healthcare), but prior publications in Pompe disease research are not a prerequisite for applying. If you are interested in submitting your research to the Young Investigator Excellence in Research Programme, please send your abstract to Amicus via the email amicusyounginvestigators@comradis.biz before the deadline on 6 January 2023.

The ERNs are co-funded by the
European Union (Health Programme and CEF)

EU Commission


“EURO-NMD is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. The ERNs are co-funded by the European Union (Health Programme and CEF).
For more information about the ERNs and the EU health strategy,
please visit ec.europa.eu/health/ern